PDCD1 and cancer: Indeed like TIM-3, LAG-3 can be co-expressed with other ICIs like PD1 as observed in preclinical mouse tumour models and cancer patients with intratumoral T-cell dysfunction that accentuates immune escape and increased tumour growth.